Section Arrow
CYTK.NASDAQ
- Cytokinetics
Quotes are at least 15-min delayed:2026/07/19 17:42 EDT
Regular Hours
Last
 80.18
-0.18 (-0.22%)
Day High 
82.575 
Prev. Close
80.36 
1-M High
88.31 
Volume 
1.59M 
Bid
78.61
Ask
80.18
Day Low
78.27 
Open
78.99 
1-M Low
75.75 
Market Cap 
10.91B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 84.06 
20-SMA 82.93 
50-SMA 77.67 
52-W High 88.31 
52-W Low 32.89 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.85/-4.80
Enterprise Value
12.13B
Balance Sheet
Book Value Per Share
-6.09
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
88.04M
Operating Revenue Per Share
0.06
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ATAIAtaiBeckley Inc7.22+0.07+0.98%-- 
JSPRJasper Therapeutics0.885+0.111+14.34%-- 
LIMNLiminatus Pharma Inc0.123-0.0247-16.72%-- 
IOVAIovance Biotherapeutics5+0.34+7.30%-- 
RXRXRecursion Pharmaceuticals2.945-0.075-2.48%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.